DK127101B - Analogifremgangsmade til fremstilling af basisk substituerede xanthinderivater - Google Patents

Analogifremgangsmade til fremstilling af basisk substituerede xanthinderivater

Info

Publication number
DK127101B
DK127101B DK155470AA DK155470A DK127101B DK 127101 B DK127101 B DK 127101B DK 155470A A DK155470A A DK 155470AA DK 155470 A DK155470 A DK 155470A DK 127101 B DK127101 B DK 127101B
Authority
DK
Denmark
Prior art keywords
preparing basic
basic substituted
analogical procedure
xanthin derivatives
xanthin
Prior art date
Application number
DK155470AA
Other languages
Danish (da)
English (en)
Inventor
W Bestian
Original Assignee
W Bestian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1915979A external-priority patent/DE1915979C3/de
Application filed by W Bestian filed Critical W Bestian
Publication of DK127101B publication Critical patent/DK127101B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK155470AA 1969-03-28 1970-03-25 Analogifremgangsmade til fremstilling af basisk substituerede xanthinderivater DK127101B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1915979A DE1915979C3 (de) 1969-03-20 1969-03-28 1,3-Dimethyl-xanthin-Derivate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
DK127101B true DK127101B (da) 1973-09-24

Family

ID=5729638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK155470AA DK127101B (da) 1969-03-28 1970-03-25 Analogifremgangsmade til fremstilling af basisk substituerede xanthinderivater

Country Status (14)

Country Link
US (1) US3734911A (en:Method)
JP (1) JPS5417757B1 (en:Method)
AT (2) AT309463B (en:Method)
BE (1) BE748165A (en:Method)
BR (1) BR7018080D0 (en:Method)
CA (1) CA932730A (en:Method)
CH (1) CH528529A (en:Method)
DK (1) DK127101B (en:Method)
ES (1) ES377662A1 (en:Method)
FR (1) FR2035966B1 (en:Method)
GB (1) GB1289287A (en:Method)
NL (1) NL7004161A (en:Method)
NO (1) NO127618B (en:Method)
SE (1) SE385893B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81160B (en) * 1980-01-31 1982-02-24 Laroche Navarron Sa Piperazine derivatives of theophylline
IT1195267B (it) * 1980-04-15 1988-10-12 Abc Ist Biolog Chem Spa Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.
US4400381A (en) * 1981-07-31 1983-08-23 Laroche-Navarron, S.A. Piperazine derivatives of theophylline
US4374837A (en) * 1981-07-31 1983-02-22 Laroche Navarron, S.A. Piperazine derivatives of theobromine
US5164390A (en) * 1988-03-03 1992-11-17 Ortho Pharmaceutical Corporation 6-substituted purinyl piperazine derivatives
US4876257A (en) * 1988-03-03 1989-10-24 Ortho Pharmaceutical Corporation 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents
US5021574A (en) * 1988-03-03 1991-06-04 Ortho Pharmaceutical Corporation 6-substituted purinyl piperazine derivatives
DE59004149D1 (de) * 1990-07-23 1994-02-17 Siemens Ag Staubsauger mit einer in seinen Staubraum einsetzbaren Filterkassette.
AU1967495A (en) * 1994-02-18 1995-09-04 Cell Therapeutics, Inc. Intracellular signalling mediators
US7865927B2 (en) 2006-09-11 2011-01-04 Apple Inc. Enhancing media system metadata

Also Published As

Publication number Publication date
SE385893B (sv) 1976-07-26
FR2035966B1 (en:Method) 1974-10-11
NO127618B (en:Method) 1973-07-23
NL7004161A (en:Method) 1970-09-30
AT309463B (de) 1973-08-27
CH528529A (de) 1972-09-30
BR7018080D0 (pt) 1973-04-26
US3734911A (en) 1973-05-22
CA932730A (en) 1973-08-28
BE748165A (fr) 1970-09-28
JPS5417757B1 (en:Method) 1979-07-02
GB1289287A (en:Method) 1972-09-13
FR2035966A1 (en:Method) 1970-12-24
ES377662A1 (es) 1973-01-01
AT317249B (de) 1974-08-26

Similar Documents

Publication Publication Date Title
DK444478A (da) Fremgangsmaade til fremstilling af 7-acylaminocephalosporansyre-derivater
DK133780C (da) Analogifremgangsmade til fremstilling af piperidinderivater
DK122964B (da) Fremgangsmåde til fremstilling af 3-amino-4-iod-5-methylisoxazolderivater.
DK145778C (da) Analogifremgangsmaade til fremstilling af 3-phenoxyphenylalkansyre-derivater
DK133279C (da) Analogifremgangsmade til fremstilling af phenylaminoeyhanolderivater
DK133741C (da) Analogifremgangsmade til fremstilling af indankarboxamidderivater
SE386894B (sv) Analogiforfarande for framstellning av morfinanderivat
DK132659C (da) Fremgangsmade til fremstilling af alkyl-cis-chrysanthemater
SE385893B (sv) Sett att framstella diakylxantin-derivat
DK132434C (da) Analogifremgangsmade til fremstilling af derivater af 6-aminopenicillansyre
BG17579A3 (bg) Метод за получаване на имидазолиди - нови производни
DK155739C (da) Analogifremgangsmaade til fremstilling af bicyclomycinderivater
DK135380B (da) Analogifremgangsmade til fremstilling af pregnan-21-syrederivater
DK131863C (da) Analogifremgangsmade til fremstilling af thiazolino- eller thiazidino-pyrimidinderivater
DK135944C (da) Fremgangsmade til fremstilling af indolderivater
DK149105C (da) Fremgangsmaade til fremstilling af 2-aryloxyalkylmorpholinderivater
DK133240C (da) Analogifremgangsmade til fremstilling af cyklopentylaminobutanolderivater
DK132887C (da) Analogifremgangsmade til fremstilling af tetrahydropyridinderivater
DK152434C (da) Fremgangsmaade til fremstilling af l-pyroglutamyl-l-histidyl-l-prolin-amid
BG17313A3 (bg) Метод за получаване на s-нитрофурилови ппроизводни
DK131789C (da) Fremgangsmade til fremstilling af kobberphthalocyaninpigmenter
DK132276C (da) Analogifremgangsmade til fremstilling af phenylpyrazoldiazepinonforbindelser
DK136712C (da) Analogifremgangsmaade til fremstilling af hidtil ukendte ureidophenoxy-alkanolamin-derivater
BG17006A3 (bg) Метод за получаване на нови -5- нитрооурилови производни
DK136426B (da) Analogifremgangsmade til fremstilling af pregnan-21-syrederivater